Sources close to President Donald Trump's political circle
indicate that his administration is prepared to take a significant step in drug
policy by initiating a formal process to modify the classification of marijuana
within the legal framework of the United States.
If implemented, this measure could mark a significant change
in how the federal government regulates and perceives this substance, which is
currently subject to strict restrictions under national legislation.
Reclassification would involve reviewing its status on controlled substance
lists, which could open the door to new scientific research, adjustments to the
justice system, and potentially, modifications to its medical or recreational
use, depending on the category assigned.
The process, which could begin in the short term, comes amid
a growing debate surrounding cannabis regulation in different regions of the
country, where several states have already adopted more flexible approaches.
Analysts believe that such a decision would have implications both
domestically—in terms of public policy and the economy—and internationally,
where the United States plays a key role in defining regulatory standards.
Although official details regarding the scope or exact
direction of this potential reclassification have not yet been released, the
anticipated announcement has generated considerable attention among
legislators, experts, and economic sectors interested in the development of the
cannabis industry.